Trial Details
TERMINATEDBasic Information
| Clinical ID | c4275 |
|---|---|
| Identifier | NCT00752622 |
| Trial Title | Treatment With Infliximab in a Medical Setting (Study P05587) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Infliximab 5 mg/kg|BIOLOGICAL: Infliximab 5 mg/kg every 6 weeks|BIOLOGICAL: Infliximab 7 mg/kg every 8 weeks |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2008-11 |
|---|---|
| Primary Completion Date | 2010-06 |
| Completion Date | 2010-06 |